Skip to main content
CLNN
NASDAQ Life Sciences

Former Board Member Symbiosis II LLC Files Intent to Sell $1.29M in Clene Inc. Shares

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
7
Price
$6.59
Mkt Cap
$76.559M
52W Low
$2.28
52W High
$13.5
Market data snapshot near publication time

summarizeSummary

Symbiosis II LLC, a former board member of Clene Inc., has filed a Form 144 indicating intent to sell an additional 198,890 shares, valued at approximately $1.29 million, continuing a pattern of significant share dispositions.


check_boxKey Events

  • Proposed Share Sale

    Symbiosis II LLC, a former board member, intends to sell 198,890 shares of Clene Inc. common stock, valued at approximately $1.29 million.

  • Ongoing Selling Pattern

    This proposed sale follows previous sales by Symbiosis II LLC, totaling 351,110 shares for gross proceeds of over $2 million in the past three months, indicating a continued reduction of their stake.

  • Filer's Relationship

    The filer, Symbiosis II LLC, is identified as a former board member, suggesting a financial decision rather than an operational one.


auto_awesomeAnalysis

This Form 144 filing indicates that Symbiosis II LLC, a former board member, intends to sell an additional $1.29 million worth of Clene Inc. shares. This continues a pattern of significant share dispositions by this entity, following over $2 million in sales in the past three months. While the company recently announced positive FDA feedback and completed a public offering, this ongoing selling pressure from a former insider could be perceived negatively by the market, especially given the company's previously disclosed "going concern" doubts. It suggests a former insider is taking liquidity, potentially capitalizing on recent positive news.

At the time of this filing, CLNN was trading at $6.59 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $76.6M. The 52-week trading range was $2.28 to $13.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CLNN - Latest Insights

CLNN
May 11, 2026, 4:15 PM EDT
Filing Type: 144
Importance Score:
7
CLNN
May 05, 2026, 5:53 PM EDT
Filing Type: 4
Importance Score:
7
CLNN
May 05, 2026, 5:06 PM EDT
Filing Type: 8-K
Importance Score:
9
CLNN
May 05, 2026, 5:03 PM EDT
Filing Type: 424B5
Importance Score:
8
CLNN
May 05, 2026, 8:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
CLNN
May 04, 2026, 4:02 PM EDT
Filing Type: 144
Importance Score:
7
CLNN
May 04, 2026, 8:03 AM EDT
Source: Reuters
Importance Score:
9
CLNN
May 04, 2026, 8:02 AM EDT
Filing Type: 8-K
Importance Score:
9
CLNN
Apr 28, 2026, 4:10 PM EDT
Filing Type: 144
Importance Score:
7
CLNN
Apr 22, 2026, 5:55 PM EDT
Filing Type: 4
Importance Score:
7